These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 8887465

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Physiologically based pharmacokinetic modeling of arsenic in the mouse.
    Gentry PR, Covington TR, Mann S, Shipp AM, Yager JW, Clewell HJ.
    J Toxicol Environ Health A; 2004 Jan 09; 67(1):43-71. PubMed ID: 14668111
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Arsenic drinking water exposure and urinary excretion among adults in the Yaqui Valley, Sonora, Mexico.
    Meza MM, Kopplin MJ, Burgess JL, Gandolfi AJ.
    Environ Res; 2004 Oct 09; 96(2):119-26. PubMed ID: 15325872
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A physiologically based pharmacokinetic model of inorganic arsenic.
    Yu D.
    Regul Toxicol Pharmacol; 1999 Apr 09; 29(2 Pt 1):128-41. PubMed ID: 10341143
    [Abstract] [Full Text] [Related]

  • 7. Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns.
    Golub MS, Macintosh MS, Baumrind N.
    J Toxicol Environ Health B Crit Rev; 1998 Apr 09; 1(3):199-241. PubMed ID: 9644328
    [Abstract] [Full Text] [Related]

  • 8. Arsenic-induced dyslipidemia in male albino rats: comparison between trivalent and pentavalent inorganic arsenic in drinking water.
    Afolabi OK, Wusu AD, Ogunrinola OO, Abam EO, Babayemi DO, Dosumu OA, Onunkwor OB, Balogun EA, Odukoya OO, Ademuyiwa O.
    BMC Pharmacol Toxicol; 2015 Jun 05; 16():15. PubMed ID: 26044777
    [Abstract] [Full Text] [Related]

  • 9. Tissue distribution and urinary excretion of dimethylated arsenic and its metabolites in dimethylarsinic acid- or arsenate-treated rats.
    Adair BM, Moore T, Conklin SD, Creed JT, Wolf DC, Thomas DJ.
    Toxicol Appl Pharmacol; 2007 Jul 15; 222(2):235-42. PubMed ID: 17559899
    [Abstract] [Full Text] [Related]

  • 10. A biokinetic model to describe the distribution and excretion of arsenic by man following acute and chronic intakes of arsenite/arsenate compounds by ingestion.
    Adeyemi A, Garelick H, Priest ND.
    Hum Exp Toxicol; 2010 Nov 15; 29(11):891-902. PubMed ID: 20219843
    [Abstract] [Full Text] [Related]

  • 11. Comparative effects of single intraperitoneal or oral doses of sodium arsenate or arsenic trioxide during in utero development.
    Stump DG, Holson JF, Fleeman TL, Nemec MD, Farr CH.
    Teratology; 1999 Nov 15; 60(5):283-91. PubMed ID: 10525206
    [Abstract] [Full Text] [Related]

  • 12. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan.
    Huang YL, Hsueh YM, Huang YK, Yip PK, Yang MH, Chen CJ.
    Sci Total Environ; 2009 Apr 01; 407(8):2608-14. PubMed ID: 19187952
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Ha-ras transgenic (Tg.AC) mice.
    Xie Y, Trouba KJ, Liu J, Waalkes MP, Germolec DR.
    Environ Health Perspect; 2004 Aug 01; 112(12):1255-63. PubMed ID: 15345372
    [Abstract] [Full Text] [Related]

  • 15. Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms.
    Sakurai T, Kaise T, Matsubara C.
    Chem Res Toxicol; 1998 Apr 01; 11(4):273-83. PubMed ID: 9548797
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of a Physiologically Based Pharmacokinetic (PBPK) Model for Inorganic Arsenic Exposure Using Data from Two Diverse Human Populations.
    El-Masri HA, Hong T, Henning C, Mendez W, Hudgens EE, Thomas DJ, Lee JS.
    Environ Health Perspect; 2018 Jul 01; 126(7):077004. PubMed ID: 30024383
    [Abstract] [Full Text] [Related]

  • 17. Exposure to inorganic arsenic in drinking water and total urinary arsenic concentration in a Chilean population.
    Caceres DD, Pino P, Montesinos N, Atalah E, Amigo H, Loomis D.
    Environ Res; 2005 Jun 01; 98(2):151-9. PubMed ID: 15820720
    [Abstract] [Full Text] [Related]

  • 18. Quantitative imaging of arsenic and its species in goat following long term oral exposure.
    Patra PH, Bandyopadhyay S, Kumar R, Datta BK, Maji C, Biswas S, Dash JR, Sar TK, Sarkar S, Manna SK, Chakraborty AK, Mandal TK.
    Food Chem Toxicol; 2012 Jun 01; 50(6):1946-50. PubMed ID: 22497900
    [Abstract] [Full Text] [Related]

  • 19. Urinary arsenic speciation profiles in mice subchronically exposed to low concentrations of sodium arsenate in drinking water.
    Wu H, Krishnamohan M, Lam PK, Ng JC.
    Kaohsiung J Med Sci; 2011 Sep 01; 27(9):417-23. PubMed ID: 21914530
    [Abstract] [Full Text] [Related]

  • 20. Risk assessment of arsenic-induced internal cancer at long-term low dose exposure.
    Liao CM, Shen HH, Chen CL, Hsu LI, Lin TL, Chen SC, Chen CJ.
    J Hazard Mater; 2009 Jun 15; 165(1-3):652-63. PubMed ID: 19062162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.